Levodopa Infusion Better Than Pills at Reducing Parkinson’s Symptoms

Translate to Spanish or other 102 languages!

Parkinson’s disease affects over 8.5 millionTrusted Source individuals worldwide, and prevalence has doubled in the past 25 years.. Image for illustration purposes
Parkinson’s disease affects over 8.5 millionTrusted Source individuals worldwide, and prevalence has doubled in the past 25 years.. Image for illustration purposes
- Advertisement -
  • Parkinson’s disease is the fastest growing neurological condition in the world, and the reasons for this are unclear. 
  • One of the main drugs offered to people with Parkinson’s disease is levodopa, which helps with symptoms affecting movement. 
  • A global team of researchers have now shown that the efficacy of the drug can be improved by being administered continuously via a pump, rather than orally, which is how it is usually taken. 

Parkinson’s disease affects over 8.5 millionTrusted Source individuals worldwide, and prevalence has doubled in the past 25 years.

Follow the link below to read the full story on Medical News Today: 

https://www.medicalnewstoday.com/articles/levodopa-infusion-better-than-pills-at-reducing-parkinsons-symptoms

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

The Truth About Liver Detoxes

Many health trends seem to come and go, but there are some that always find a way of resurfacing – like detoxing your liver.

STHS Children’s Webinar to Help Parents Protect Young Athletes from Sports-Related Injuries, Aug. 19th

Whether competing in youth sports, high school athletics or recreational leagues, young athletes continually push themselves to perform at their best. 

CDC Issues Warning Over Multistate Salmonella Outbreak Linked to Jalapeños

The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections linked to contaminated jalapeño peppers

New Blood Test Spots Early Signs of Immunotherapy Effectiveness

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.
- Advertisement -